Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

P. Bonaca, Marc; L. Bhatt, Deepak; Cohen, Marc; Gabríel Steg, Philippe; F. Storey, Robert; C. Jensen, Eva; Magnani, Giulia; Bansilal, Sameer; Polly Fish, M.; Im, KyungAh; Bengtsson, Olof; Oude Ophuis, Ton; Budaj, Andrzej; Théroux, Pierre; Ruda, Mikhail; Hamm, Christian; Goto, Shinya; Špinar, Jindřich; Carlos Nicolau, José; Gábor Kiss, Róbert; A. Murphy, Sabina; Wiviott, Stephen; Held, Peter; Braunwald, Eugene; S. Sabatine, Marc

doi:10.1056/nejmoa1500857

Public

Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

Published in New England Journal of Medicine • Mar 14, 2015

Authors:

Marc P. Bonaca

Deepak L. Bhatt

Marc Cohen

Abstract

BACKGROUND: The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y12 receptor antagonist with established efficacy after an acute coronary syndrome, in this context. METHODS...

Subject

Ticagrelor

Term (time)

Myocardial infarction

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!